LIKE I SAID A FEW DAYS AGO.ALL IT DOES THIS POS.IS OFFERINGS TO SELL SHARES.THESE GUYS ARE SCAMBAGS BIG TIME.THIS POS IS HEADED FOR ANOTHER R/S IMO.
ORCA Member Level Friday, 09/28/18 10:35:45 AM
Re: None 0
Post #
1107
of 1133
ALL IT DOES THIS POS.IS OFFERINGS TO SELL SHARES.THESE GUYS ARE SCAMBAGS BIG TIME.THIS POS IS HEADED FOR ANOTHER R/S IMO.
We are offering 15,384,615 shares of our common stock. We are also offering to certain purchasers whose purchase of shares of common stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock immediately following the consummation of this offering, the opportunity to purchase, if any such purchaser so chooses, pre-funded warrants, in lieu of shares of common stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock. The purchase price of each pre-funded warrant will be equal to the price per share at which shares of common stock are sold to the public in this offering, minus $0.01, and the exercise price of each pre-funded warrant will be $0.01 per share. This offering also relates to the shares of common stock issuable upon exercise of any pre-funded warrants sold in this offering. The pre-funded warrants will be exercisable immediately and may be exercised at any time until all of the pre-funded warrants are exercised in full. For each pre-funded warrant we sell, the number of shares of common stock we are offering will be decreased on a one-for-one basis. Our common stock is listed on The NASDAQ Capital Market under the symbol "JAGX." On September 24, 2018, the last reported sale price of our common stock was $0.65 per share.
Knight Therapeutics Inc ("Knight"), our Licensee for Canada and Israel, has given a non-binding indication of interest to purchase up to $1,000,000 in this offering at the public offering price, provided that we raise at least $9,000,000. This is not a commitment to purchase; therefore, Knight may not purchase any common stock in this offering. See Recent Developments on page 2 of this prospectus.
We are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings.
Our business and an investment in our securities involves a high degree of risk. See "Risk Factors" beginning on page 8 of this prospectus for a discussion of information that you should consider before investing in our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
